The Lancet Rheumatology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 29.5 | Q1 | 98.3% | 6.167 | Q1 | 99.3% |
| 2024 | 16.4 | Q1 | 96.6% | 3.837 | Q1 | 98.5% |
| 2023 | 15.0 | Q1 | 96.5% | 3.717 | Q1 | 98.5% |
| 2022 | 25.4 | Q1 | 96.4% | 4.586 | Q1 | 99.0% |
| 2021 | 35.5 | Q1 | 100.0% | 6.633 | Q1 | 99.5% |
| 2020 | — | — | 1.657 | Q1 | 93.6% | |
| 2019 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
2665-9913
country
coverage
2019-2026
